These findings are consistent with an earlier study identifying improved colostomy-free survival (90 vs 50%, P=0.04) in patients with tumours of higher proliferative potential as measured by the MiB1 index (Grabenbauer et al, 1998). Here, MIB1 is linked to neoplasm.